Literature DB >> 27003420

Unit 731 and moral repair.

Doug Hickey1, Scarllet SiJia Li1, Celia Morrison1, Richard Schulz1, Michelle Thiry1, Kelly Sorensen1.   

Abstract

Unit 731, a biological warfare research organisation that operated under the authority of the Imperial Japanese Army in the 1930s and 1940s, conducted brutal experiments on thousands of unconsenting subjects. Because of the US interest in the data from these experiments, the perpetrators were not prosecuted and the atrocities are still relatively undiscussed. What counts as meaningful moral repair in this case-what should perpetrators and collaborator communities do decades later? We argue for three non-ideal but realistic forms of moral repair: (1) a national policy in Japan against human experimentation without appropriate informed and voluntary consent; (2) the establishment of a memorial to the victims of Unit 731; and (3) US disclosure about its use of Unit 731 data and an apology for failing to hold the perpetrators accountable. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Chemical and Biological Weapons; Codes of/Position Statements on Professional Ethics

Mesh:

Year:  2016        PMID: 27003420     DOI: 10.1136/medethics-2015-103177

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  2 in total

1.  Human rights violations in organ procurement practice in China.

Authors:  Norbert W Paul; Arthur Caplan; Michael E Shapiro; Charl Els; Kirk C Allison; Huige Li
Journal:  BMC Med Ethics       Date:  2017-02-08       Impact factor: 2.652

Review 2.  Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.

Authors:  Wendy Rogers; Matthew P Robertson; Angela Ballantyne; Brette Blakely; Ruby Catsanos; Robyn Clay-Williams; Maria Fiatarone Singh
Journal:  BMJ Open       Date:  2019-02-05       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.